Neuphoria Therapeutics Balance Sheet (2020-2026)

Reported Financials

Neuphoria Therapeutics Quarterly Balance Sheet

Periods 19 quarters

Latest Jun 2026

Neuphoria Therapeutics reported total assets of $28.71M and total liabilities of $4.11M for the quarter ended Jun 2026, up 0.4% year over year. This balance sheet covers 19 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet	Jun2020	Dec2020	Jun2021	Dec2021	Jun2022	Dec2022	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	3.15M		21.41M	29.25M	23.09M	30.70M	12.08M	8.14M	10.15M	8.43M	12.61M	8.08M	4.34M	17.04M	14.21M	13.65M	22.20M	19.44M	19.90M
Short-term InvestmentsInvestments (Current)			0.33M	0.09M	0.08M	0.12M	0.08M		0.12M
Cash & Current Investments	3.15M		21.74M	29.34M	23.18M	30.82M	12.16M	8.14M	10.27M	8.43M	12.61M	8.08M	4.34M	17.04M	14.21M	13.65M	22.20M	19.44M	19.90M
Receivables - NetNet Receivables	0.72M		0.15M	0.02M	0.04M	0.04M	0.01M		0.48M		0.13M	0.12M	0.04M	0.02M	0.01M	0.00M	1.11M	1.61M	0.81M
Receivables - OtherOther Receivables	0.53M	2.24M	0.70M	0.80M	4.62M	6.72M	0.42M		0.15M		0.10M	0.10M					0.49M	0.81M	0.81M
Receivables	1.25M		0.85M	0.81M	4.67M	6.76M	0.43M		0.62M		0.22M	0.22M	0.04M	0.02M	0.01M	0.00M	1.60M	2.41M	1.62M
Inventory	0.48M
Prepaid Assets			0.65M	2.27M		2.28M	0.80M		1.37M		0.46M	0.23M	0.02M	0.02M	0.74M	0.22M	0.03M	0.61M	0.39M
Current Assets			23.24M	32.33M	28.77M	33.15M	13.30M		16.86M		13.19M	8.43M	4.40M	17.09M	15.04M	13.95M	23.39M	21.66M	21.07M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)	1.38M		0.01M	3.39M	0.00M	4.48M	0.00M		3.11M		0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Goodwill	8.85M		9.32M	9.11M	8.85M	12.95M	8.66M	8.57M	8.84M	8.63M	8.69M	8.90M	8.41M	8.45M	8.64M	8.67M	8.74M	8.84M	3.50M
Intangibles	16.70M		7.47M	7.10M	6.77M	9.50M	6.09M	5.96M	5.80M	5.63M	5.47M	5.30M	5.14M	4.97M	4.80M	4.64M	4.47M	4.31M	4.14M
Goodwill & Intangibles	25.55M		7.47M	16.21M	6.77M	22.45M	6.09M	14.54M	14.64M	14.26M	6.95M	14.21M	13.54M	13.42M	13.44M	13.31M	13.21M	13.15M	7.64M
Other Non-Current Assets	0.06M		0.65M		1.01M		0.08M		0.08M	0.08M	0.08M	0.08M	0.07M	0.07M	0.08M	0.08M	0.08M
Non-Current Assets			17.53M	16.85M	16.17M	23.16M	15.16M		22.00M		14.46M	14.49M	13.77M	13.62M	13.55M	13.39M	13.21M	13.15M	7.64M
Assets	0.75M		40.77M	49.18M	44.94M	56.31M	28.47M		38.85M		27.65M	22.92M	18.17M	30.71M	28.59M	27.34M	36.60M	34.81M	28.71M
Liabilities
Current Liabilities
Accounts Payables	1.59M		1.36M	2.00M	1.92M	3.09M	2.32M		2.56M		2.24M	1.33M	1.53M	0.75M	1.15M	1.37M	0.52M	0.63M	0.39M
Payables	1.59M		1.36M	2.00M	1.92M	3.09M	2.32M		2.56M		2.24M	1.33M	1.53M	0.75M	1.15M	1.37M	0.52M	0.63M	0.39M
Accumulated Expenses							1.19M				1.46M	1.10M	0.79M	0.68M	2.95M	3.67M	2.07M	0.89M	0.37M
Other Accumulated Expenses	-0.56M						0.04M				0.31M	0.08M	0.03M	0.03M	0.28M	0.11M	0.10M	0.17M	0.05M
Current Taxes	-0.75M
Current Deferred Tax LiabilityCurrent Deferred Tax																			15.00
Total Current Liabilities			1.77M	2.40M	2.31M	3.66M	2.73M		4.42M		3.83M	2.55M	2.13M	1.55M	4.22M	5.12M	2.59M	1.51M	0.76M
Non-Current Liabilities
Capital Leases	-0.88M		0.52M		0.37M		0.24M
Non-Current Debt					4.25M		5.11M
Liabilities from Discontinued OperationsLiabilities from Discont. Ops	0.00M
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax	-0.35M		1.38M	1.31M	1.24M	1.72M	1.10M		1.52M		0.96M	0.83M	0.84M	0.76M	0.50M	0.46M	0.43M	0.39M	0.36M
Operating Leases	0.02M		0.52M	0.01M	0.37M	0.02M	0.24M		0.00M		0.12M	0.09M	0.05M	0.02M	0.12M	0.09M
Other Non-Current Liabilities	-0.14M		1.32M	1.32M	1.86M	2.74M	2.47M		3.61M		5.25M	2.37M	1.39M	2.38M	4.87M	9.25M	3.89M	3.48M	3.00M
Total Non-Current Liabilities	-7.82M		3.23M	3.08M	3.47M	4.93M	3.79M		5.40M		4.91M	3.47M	3.03M	2.33M	4.72M	5.58M	3.01M	1.90M	1.11M
Total Liabilities	-7.96M		5.01M	5.48M	5.78M	-167.19M	6.52M		19.36M		10.16M	5.85M	4.42M	4.72M	9.59M	14.83M	6.90M	5.39M	4.11M
Shareholder's Equity
Total Debt					4.25M		5.11M		1.12M
Common Equity	8.71M	117.13M	35.76M	43.70M	39.16M	223.50M	21.94M	17.23M	19.50M	17.95M	17.49M	17.07M	13.75M	26.00M	19.00M	12.51M	29.70M	29.42M	24.60M
Liabilities and Shareholders Equity	0.75M		40.77M	49.18M	44.94M	56.31M	28.47M		38.85M		27.65M	22.92M	18.17M	30.71M	28.59M	27.34M	36.60M	34.81M	28.71M
Retained Earnings			-115.74M	-119.40M	-119.24M	-189.23M	-162.48M		-218.63M		-177.98M	-178.80M	-180.73M	-169.50M	-178.35M	-188.30M	-186.40M	-186.90M	-191.80M

Neuphoria Therapeutics Balance Sheet API

Pull Neuphoria Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=NEUP&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "NEUP", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=NEUP&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

Neuphoria Therapeutics NEUP Balance Sheet (2020-2026)

Neuphoria Therapeutics Quarterly Balance Sheet

Neuphoria Therapeutics Balance Sheet API

Create an account

Sign In

Reset Password